eye disease

Novartis Considers Offer for Takeda Eye-Disease Assets
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Novartis
Takeda
Shire
eye disease
M&A
Flag link:
How this biotech plans to go up against big pharma with its eye disease products
How this biotech plans to go up against big pharma with its eye disease products
Drug Delivery Business News
biotech
Ocugen
eye disease
Flag link:
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Yahoo
Bayer
Regeneron
eye disease
nesvacumab
Aflibercept
Flag link:
Biogen enters eye-treatment arena with AGTC deal
Biogen enters eye-treatment arena with AGTC deal
Yahoo/Reuters
Biogen
M&A
AGTC
opthalmology
gene therapy
eye disease
Flag link:
Bayer bets on Johns Hopkins for eye disease R&D
Bayer bets on Johns Hopkins for eye disease R&D
Fierce Biotech
Bayer
eye disease
R&D
Johns Hopkins
Flag link:
Two Promising Gene Therapy Stocks Tackling Eye Disease
Two Promising Gene Therapy Stocks Tackling Eye Disease
TheStreet.com
Applied Genetic Technologies
Avalanche Biotechnologies
eye disease
Flag link:
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
Iridex
eye disease
Flag link:
Otsuka Pharma extends research collaboration with MethylGene
Otsuka Pharma extends research collaboration with MethylGene
Pharmabiz
Otsuka
MethylGene
eye disease
Flag link:
Alcon Boosts Presence In Eye Disease Market
Alcon Boosts Presence In Eye Disease Market
Yahoo/Investors Business Daily
eye disease
Alcon
Flag link: